Capital Investment Services of America’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.4M Buy
114,849
+440
+0.4% +$91.2K 2.19% 19
2026
Q1
$25.7M Sell
114,409
-283
-0.2% -$70.5K 2.68% 10
2025
Q4
$27.6M Sell
114,692
-3,137
-3% -$802K 2.61% 14
2025
Q3
$32.3M Buy
117,829
+188
+0.2% +$51.4K 2.87% 8
2025
Q2
$30.4M Buy
117,641
+211
+0.2% +$50.3K 2.78% 14
2025
Q1
$26.3M Sell
117,430
-997
-0.8% -$233K 2.66% 16
2024
Q4
$27.1M Sell
118,427
-1,961
-2% -$472K 2.58% 16
2024
Q3
$29.4M Sell
120,388
-7,840
-6% -$1.75M 2.8% 13
2024
Q2
$24.5M Sell
128,228
-2,740
-2% -$556K 2.37% 19
2024
Q1
$25.9M Buy
130,968
+11,747
+10% +$2.15M 2.5% 19
2023
Q4
$20.5M Buy
119,221
+740
+0.6% +$114K 2.15% 24
2023
Q3
$17.5M Buy
118,481
+2,080
+2% +$376K 2.03% 25
2023
Q2
$25.4M Sell
116,401
-125
-0.1% -$27.9K 2.78% 13
2023
Q1
$25.5M Sell
116,526
-11,459
-9% -$2.49M 3.08% 9
2022
Q4
$26.6M Sell
127,985
-1,464
-1% -$322K 3.53% 6
2022
Q3
$28.3M Sell
129,449
-663
-0.5% -$151K 3.84% 4
2022
Q2
$27.3M Sell
130,112
-4,441
-3% -$945K 3.54% 4
2022
Q1
$35M Hold
134,553
3.18% 5
2021
Q4
$35M Sell
134,553
-2,849
-2% -$739K 3.18% 5
2021
Q3
$36.2M Sell
137,402
-4,741
-3% -$1.3M 3.45% 6
2021
Q2
$35M Sell
142,143
-2,310
-2% -$486K 3.34% 6
2021
Q1
$28M Sell
144,453
-2,192
-1% -$440K 2.89% 9
2020
Q4
$31.2M Buy
146,645
+2,690
+2% +$536K 3.26% 6
2020
Q3
$24.7M Sell
143,955
-9,397
-6% -$1.74M 3.01% 9
2020
Q2
$29.4M Sell
153,352
-1,230
-0.8% -$201K 3.8% 5
2020
Q1
$22.8M Sell
154,582
-360
-0.2% -$57.3K 3.66% 6
2019
Q4
$24M Sell
154,942
-565
-0.4% -$81.4K 3.23% 6
2019
Q3
$21M Buy
155,507
+618
+0.4% +$81K 3.1% 6
2019
Q2
$18.9M Buy
154,889
+365
+0.2% +$40.4K 2.78% 13
2019
Q1
$16.1M Buy
154,524
+1,932
+1% +$199K 2.57% 17
2018
Q4
$17.4M Sell
152,592
-3,775
-2% -$404K 3.1% 8
2018
Q3
$18M Sell
156,367
-6,885
-4% -$754K 2.71% 10
2018
Q2
$16.9M Sell
163,252
-3,774
-2% -$382K 2.66% 11
2018
Q1
$16.4M Sell
167,026
-16,135
-9% -$1.52M 2.57% 9
2017
Q4
$15.5M Sell
183,161
-23,900
-12% -$1.97M 2.46% 10
2017
Q3
$15.9M Sell
207,061
-4,585
-2% -$351K 2.68% 7
2017
Q2
$16.5M Sell
211,646
-1,535
-0.7% -$110K 2.84% 7
2017
Q1
$15.3M Sell
213,181
-2,515
-1% -$174K 2.71% 9
2016
Q4
$13.4M Sell
215,696
-70
-0% -$4.29K 2.53% 12
2016
Q3
$14M Sell
215,766
-10,790
-5% -$718K 2.67% 10
2016
Q2
$14.3M Sell
226,556
-1,575
-0.7% -$92.8K 2.73% 10
2016
Q1
$13.2M Sell
228,131
-1,975
-0.9% -$112K 2.51% 15
2015
Q4
$12.4M Sell
230,106
-125
-0.1% -$7.05K 2.42% 16
2015
Q3
$11.7M Buy
230,231
+3,326
+1% +$179K 2.81% 12
2015
Q2
$12.8M Buy
226,905
+3,215
+1% +$203K 2.92% 10
2015
Q1
$16.1M Sell
223,690
-555
-0.2% -$36K 3.69% 2
2014
Q4
$12.6M Buy
224,245
+500
+0.2% +$26.1K 2.92% 8
2014
Q3
$11M Sell
223,745
-2,905
-1% -$148K 2.8% 15
2014
Q2
$11.5M Buy
226,650
+450
+0.2% +$22.3K 2.84% 12
2014
Q1
$10.1M Buy
226,200
+1,775
+0.8% +$79.7K 2.54% 23
2013
Q4
$10.6M Buy
224,425
+800
+0.4% +$40.5K 2.67% 17
2013
Q3
$11.8M Sell
223,625
-1,145
-0.5% -$55.5K 3.14% 8
2013
Q2
$10.1M Buy
+224,770
New +$10.7M 2.92% 13

Other funds holding RMD

Capital Investment Services of America's RMD Position: Q2 2026 in Review

Capital Investment Services of America increased its ResMed (RMD) stake by 0.38% in Q2 2026, buying an estimated $91.2K and bringing the position to 114,849 shares worth $22.4M. The position accounts for 2.19% of the portfolio, ranked #19.

Capital Investment Services of America first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $36.2M in Q3 2021. 605 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Capital Investment Services of America held 114,849 shares of ResMed worth $22.4M as of Q2 2026.
  • Capital Investment Services of America bought 440 ResMed shares in Q2 2026, an estimated $91.2K.
  • ResMed made up 2.19% of Capital Investment Services of America's portfolio in Q2 2026, its #19 holding.
  • Capital Investment Services of America first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
  • Capital Investment Services of America's ResMed position peaked at $36.2M in Q3 2021.
  • 605 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Capital Investment Services of America's 13F filing for Q2 2026, filed 22 Jul 2026.